相关实验视频
Updated: May 15, 2025

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
19.1K
重新考虑在瘤学中使用皮质类固醇
Pierrick Martinez1, Jean-Marc Sabatier2
1Association Cancer et Métabolisme, Nîmes, France.
Frontiers in pharmacology
|April 10, 2025
概括
皮质类固醇 (CSs) 控制癌症症状,但可能通过改变新陈代谢和微生物群来损害生存. 性饮食和维生素D等替代策略显示出对更安全的癌症护理的承诺.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 代谢研究的研究.
背景情况:
- 皮质类固醇 (CSs) 常用于癌症治疗,用于症状管理和抗炎作用.
- 长期使用CS与不良结果有关,包括降低患者存活率和加速瘤进展.
- 关键的机制包括改变的葡萄糖/胺代谢,破坏的维生素D和微生物组的变化.
研究的目的:
- 评估长期使用皮质类固醇在瘤学中的风险.
- 探索模仿CS益处的替代治疗策略,同时减轻不良影响.
- 倡导在癌症治疗中重新评估皮质类固醇方案.
主要方法:
- 文献综述和综合关于皮质类固醇在癌症中的当前研究.
- 分析受CSs影响的代谢途径 (葡萄糖,谷氨酸).
- 调查替代干预措施 (基因饮食,禁食,沙坦,维生素D).
主要成果:
- 皮质类固醇可以对癌症患者的生存产生负面影响,并促进瘤的生长.
- 代谢失调,维生素D缺乏和微生物组变化是关键因素.
- 新兴策略显示,有可能提供类似的好处,同时降低瘤风险.
结论:
- 需要对癌症患者的皮质类固醇使用进行批判性重新评估.
- 替代性和补充性疗法可能为症状管理和支持性护理提供更安全的选择.
- 进一步的研究对于开发和验证癌症治疗的新型治疗策略至关重要.
更多相关视频
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
156
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
156
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
108
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
108
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K

